Rise Biopharmaceuticals, Inc.   Report issue

For profit Phase 1
Founded: Beijing China (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2020
NCT04338763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Rise Biopharmaceuticals, Inc.